ISPE Announces Featured Speakers for Signature Bio Manufacturing and Process Validation Events

News provided by

International Society for Pharmaceutical Engineering (ISPE)

Apr 16, 2019, 07:00 ET

BETHESDA, Md. (PRWEB) April 16, 2019 -- The International Society for Pharmaceutical Engineering (ISPE) announced its featured speakers for two signature events: The 2019 ISPE Biopharmaceutical Manufacturing Conference, on 18–20 June and The 2019 ISPE Process Validation Workshop on 20–21 June. Taking place in one of the most influential bio hubs, Boston, Massachusetts USA, these concurrent events bring together regulators and pharmaceutical industry experts to address top biomanufacturing and process validation issues.

Featured Speakers for the ISPE Biopharmaceutical Manufacturing Conference include leading biopharma experts and regulatory leaders:

  • Peter Marks, MD, Director, CBER, FDA
  • Mark Bamforth, President and CEO, Brammer Bio
  • Steve Bagshaw, CEng, FIChemE, Chief Executive Officer, Fujifilm Diosynth Biotechnologies
  • Eric Langer, President and Managing Partner, BioPlan Associates, Inc.

Featured Speakers for the ISPE Process Validation Workshop include regulatory leaders and technical experts for bio process validation:

  • Maneesha Altekar, Sr. Technical Manager, Product Robustness CoE, AstraZeneca
  • Alexey Khrenov, Senior Staff Fellow, CBER, FDA
  • Christopher Pastorello, Assistant Director, CAR-T Validation, Celgene
  • Thanmaya Peram, Senior Engineer and Group Leader, Roche/Genentech
  • Tara Scherder, Partner, SynoloStats
  • Louis Traglia, Principal Consultant, Commissioning Agents, Inc.
  • Keith Webber, Vice President, Biotechnology, Lachman Consultant Services

To learn more about these events, visit http://www.ISPE.org/Bio19 and http://www.ISPE.org/PV19.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: [email protected]
http://www.ISPE.org

Maria Robertson, International Society for Pharmaceutical Engineering (ISPE), http://www.ISPE.org, 301-364-9207, [email protected]